Skip to main content
Bioera logo

Bioera — Investor Relations & Filings

Ticker · BIE ISIN · IT0005516130 LEI · 815600CE609AFE44D992 XMIL Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2022-08-25 AGM Information
Country IT Italy
Listing XMIL BIE

About Bioera

https://bioera.it/en/

Bioera S.p.A. is a company specializing in the production and distribution of natural and organic products. Its core business involves the development and marketing of a diverse portfolio that includes organic food, traditional food products, natural cosmetics, herbal remedies, and food supplements. The company focuses on providing consumers with products derived from natural sources, catering to the health and wellness market.

Recent filings

Filing Released Lang Actions
BIOERA SPA AVVISO DI CONVOCAZIONE DELL'ASSEMBLEA STRAORDINARIA
AGM Information Classification · 1% confidence The document is titled "Avviso di convocazione dell'Assemblea Straordinaria di Bioera S.p.A." (Notice of Extraordinary Shareholders' Meeting of Bioera S.p.A.). It details the date, time, location, and the specific agenda items (ORDINE DEL GIORNO) for an upcoming shareholders' meeting, including proposals related to bond issuance, capital increases, and share grouping. This content directly relates to materials shared for an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). Since the primary purpose is to announce and detail the meeting itself, the most appropriate classification is AGM Information (AGM-R). It is not a proxy statement (PSI) as it is the notice itself, nor is it a declaration of voting results (DVA), which happens after the meeting.
2022-08-25 Italian
BIOERA S.P.A COMUNICATO STAMPA AZIONISTI RILEVANTI
Major Shareholding Notification Classification · 1% confidence The document is a press release (COMUNICATO STAMPA) from BIOERA S.p.A. The subject (Oggetto) is 'AZIONISTI RILEVANTI' (Relevant Shareholders). The text explicitly states that an existing shareholder has crossed the 5% voting capital threshold and provides an updated breakdown of the shareholding structure. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2022-08-13 Italian
Emissione di un prestito obbligazionario convertibile "cum warrant" da 9,0 milioni. Convocazione dell'Assemblea Straordinaria degli azionisti
Capital/Financing Update Classification · 1% confidence The document is an official regulatory announcement (indicated by the header 'Informazione Regolamentata n. 0771-34-2022' and 'Data/Ora Ricezione 05 Agosto 2022 17:59:42') detailing a significant corporate action: the issuance of a convertible bond ('prestito obbligazionario convertibile cum warrant') worth Euro 9.0 million and the subsequent convocation of an Extraordinary Shareholders' Meeting to approve related capital increases and a share grouping proposal. This type of announcement, concerning fundraising, capital structure changes, and calling a meeting for approval, falls under 'Capital/Financing Update' (CAP). While it mentions convening an assembly (which might suggest AGM-R or PSI), the primary focus and substance of the release is the financing deal itself (issuance of debt/equity instruments). It is not a full report (10-K, IR), a transcript (CT), or just a dividend notice (DIV). Therefore, CAP is the most appropriate classification.
2022-08-05 Italian
BIOERA S.P.A INFORMATIVA AL MERCATO AI SENSI DELL'ART. 114, COMMA 5, D. lgs. n. 58/98 ( "TUF") PERIODO DI RIFERIMENTO: 30.06.2022
Management Reports Classification · 1% confidence The document is an official communication from BIOERA S.P.A. titled "Informativa al mercato ai sensi dell'art. 114, comma 5, D.lgs. n. 58/98 ("TUF")" for the reference period ending 30.06.2022. This type of filing, mandated by Italian law (TUF Article 114, paragraph 5) to Consob, requires the disclosure of specific financial data, namely net financial debt and overdue payables, between official periodic reports. Since this is a mandatory, specific disclosure of financial status for an interim period (mid-year data provided in July), it aligns best with the definition of an Interim / Quarterly Report (IR), which covers comprehensive financial reporting for periods shorter than a year. Although it is a specific disclosure, it contains detailed financial tables (net debt, overdue payables breakdown) rather than just announcing a full report, making IR more appropriate than RPA or RNS. The reference period 30.06.2022 strongly suggests a half-year report context.
2022-07-29 Italian
BIOERA SPA ESTENSIONE DEL TERMINE DI RIMBORSO DEL DEBITO RESIDUO DI CUI ALLA DEBENTURE NOTE 2018-2021 EMESSA DALLA SOCIETA'
Capital/Financing Update Classification · 1% confidence The document is a formal announcement ('Informazione Regolamentata') from an Italian listed company (BIOERA S.p.A. on Euronext Milan). The subject ('Oggetto') explicitly states 'ESTENSIONE DEL TERMINE DI RIMBORSO DEL DEBITO RESIDUO' (Extension of the repayment term of residual debt) concerning a Debenture Note. This clearly relates to changes in the company's financing or capital structure, specifically debt management. This aligns best with the 'Capital/Financing Update' category (CAP). Although it is a formal regulatory filing, the specific content points directly to financing activities rather than a general regulatory notice (RNS) or a report announcement (RPA). The document is short and contains the core information, making it a direct announcement rather than a fallback.
2022-07-29 Italian
Nomina del Dott. Pecere a Dirigente Preposto alla redazione documenti contabili societari di Bioera SpA e Variazione del Calendario Finanziario 2022
Board/Management Information Classification · 1% confidence The document is a formal regulatory announcement (Informazione Regolamentata) from Euronext Milan. The subject ('Oggetto') explicitly states two key items: 1) Appointment of Dr. Pecere as the executive responsible for preparing corporate accounting documents ('dirigente preposto alla redazione dei documenti contabili societari'), and 2) Variation of the Financial Calendar ('Variazione del Calendario Finanziario'). The appointment of a key executive/director falls directly under the 'Board/Management Information' category (MANG). Although it also mentions a change in the financial calendar (which relates to future reporting), the primary, immediate corporate governance action is the appointment of a key officer. This is a specific announcement about management structure, not a general regulatory filing (RNS) or a report itself (like IR or ER).
2022-07-22 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.